Preclinical News and Research

RSS
CHLA develops first fully-implantable micropacemaker for use in fetus with complete heart block

CHLA develops first fully-implantable micropacemaker for use in fetus with complete heart block

CFDA accepts WuXi MedImmune's novel anti-IL6 monoclonal antibody IND application for review

CFDA accepts WuXi MedImmune's novel anti-IL6 monoclonal antibody IND application for review

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Aridis Pharmaceuticals begins Aerucin Phase 1 clinical study for treatment of acute pneumonia

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Arno Therapeutics' AR-42 with cisplatin demonstrates anti-tumor effect in bladder cancer models

Mexican researcher close to finding a cure for Parkinson's disease

Mexican researcher close to finding a cure for Parkinson's disease

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

Dipexium Pharmaceuticals reports strong financial results for year ended December 31, 2014

A new approach to TBI therapy

A new approach to TBI therapy

Deuterium-containing sigma-1 agonist demonstrates anti-seizure, anti-inflammatory effects in TBI model

Deuterium-containing sigma-1 agonist demonstrates anti-seizure, anti-inflammatory effects in TBI model

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

Isis Pharmaceuticals announces positive results from ISIS-ANGPTL3Rx Phase 1 study

Study shows how PDT for pancreatic cancer can be included in physician practice without significant cost

Study shows how PDT for pancreatic cancer can be included in physician practice without significant cost

Discovery may lead to new potential treatment for drug-resistant melanoma

Discovery may lead to new potential treatment for drug-resistant melanoma

Eli Lilly, Innovent Biologics announce biotech drug development collaborations in China

Eli Lilly, Innovent Biologics announce biotech drug development collaborations in China

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

New pre-clinical, clinical data for IMBRUVICA to be highlighted at AACR Annual Meeting

PaMZ drug regimen shows potential to improve treatment for MDR-TB

PaMZ drug regimen shows potential to improve treatment for MDR-TB

New MR Solutions maintenance and upgrade service available for Agilent MRI systems

New MR Solutions maintenance and upgrade service available for Agilent MRI systems

Researchers working to develop non-invasive diagnostic technique for detecting Alzheimer's early

Researchers working to develop non-invasive diagnostic technique for detecting Alzheimer's early

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

Pharmalink AB acquires anti-inflammatory drug candidate from Synartro AB

New drug-like molecule shows promise in preventing MS progression

New drug-like molecule shows promise in preventing MS progression

TSRI scientists confirm ribosome assembly as new target for anti-cancer drugs

TSRI scientists confirm ribosome assembly as new target for anti-cancer drugs

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

NantWorks, Sorrento collaborate to discover and develop novel anti-cancer immunotherapies

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.